INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title:
Development And Validation Of Stability Indicating RP-HPLC Method For Simultaneous Estimation Of Remogliflozin And Vildagliptin In Pharmaceutical Dosage Form.
Authors Name:
Patel Richiben Vinodbhai
, Dr. Hiral Panchal , Ms. Foram Patel , Ms. Ayushi Patel
The present study was focused to develop a simple, precise, accurate and cost effective RP-HPLC method for estimation of Remogliflozin etabonate and Vildagliptin from pharmaceutical dosage form. The chromatographic method was carried out using Agilent C18 (150mm*4.6mm) 5µm using mobile phase (Methanol: Buffer (pH3.5): ACN (55:35:10 %v/v)). The flow rate was set 1.0ml/min with 20µL injection volume. Total run time 10min. Detection was carried out at wavelength of 254nm. The detector response was linear in the range of 150-450μg/ml for Remogliflozin etabonate and 75-225μg/ml for Vildagliptin. The % recoveries for Remogliflozin etabonate and Vildagliptin obtained in the accuracy study were 99.07-100.38% and 99.69-100.70% respectively. The LOD for Remogliflozin etabonate and Vildagliptin were found to be 0.0053μg/ml and 0.0038μg/ml respectively. LOQ for Remogliflozin etabonate and Vildagliptin were found to be 0.016μg/ml and 0.0011μg/ml respectively. Remogliflozin etabonate and Vildagliptin were also subjected to various stress condition like acid and alkali hydrolysis, oxidation, photolysis, and thermal degradation. The developed method is successfully applied for estimation of Remogliflozin etabonate and Vildagliptin from pharmaceutical dosage form.
"Development And Validation Of Stability Indicating RP-HPLC Method For Simultaneous Estimation Of Remogliflozin And Vildagliptin In Pharmaceutical Dosage Form.", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 4, page no.930-964, April-2022, Available :http://www.ijnrd.org/papers/IJNRD2204118.pdf
Downloads:
000114580
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn